These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 22997453)

  • 21. Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Jelic S;
    Ann Oncol; 2009 May; 20 Suppl 4():41-5. PubMed ID: 19454459
    [No Abstract]   [Full Text] [Related]  

  • 22. [Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)].
    Department of Medical Administration, National Health and Health Commission of the People's Republic of China
    Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):112-128. PubMed ID: 32164061
    [No Abstract]   [Full Text] [Related]  

  • 23. [Updated guide for diagnosis, staging and treatment of hepatocellular carcinoma].
    Gómez Senent S; Gómez Raposo C; Segura Cabral JM
    Med Clin (Barc); 2007 May; 128(19):741-8. PubMed ID: 17565883
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of hepatocellular carcinoma.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2003; 3(1):8-24. PubMed ID: 12684589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early diagnosis and treatment of patients with liver carcinoma].
    Colombo M; Piva A
    Minerva Gastroenterol Dietol; 1992; 38(2):53-62. PubMed ID: 1327179
    [No Abstract]   [Full Text] [Related]  

  • 26. The effectiveness of selective internal radiation therapy in challenging cases of liver-predominant unresectable hepatocellular carcinoma.
    Malfertheiner P; Verslype C; Kolligs FT; Schütte K; Vandecaveye V; Paprottka PM; Ricke J
    Future Oncol; 2014 Nov; 10(15 Suppl):17-27. PubMed ID: 25478762
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evidence and topics of chemotherapy for hepatocellular carcinoma].
    Ueshima K; Kudo M
    Nihon Shokakibyo Gakkai Zasshi; 2017; 114(9):1621-1628. PubMed ID: 28883291
    [No Abstract]   [Full Text] [Related]  

  • 28. Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.
    Bellmunt J; Orsola A; Maldonado X; Kataja V;
    Ann Oncol; 2010 May; 21 Suppl 5():v134-6. PubMed ID: 20555063
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatocellular carcinoma: current approaches to diagnosis and management.
    McCaughan GW; Koorey DJ; Strasser SI
    Intern Med J; 2002 Aug; 32(8):394-400. PubMed ID: 12162396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.
    Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ
    Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
    Kudo M; Okanoue T;
    Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Glynne-Jones R; Northover JM; Cervantes A;
    Ann Oncol; 2010 May; 21 Suppl 5():v87-92. PubMed ID: 20555110
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of the advanced HCC: A second revolution by using immunotherapy].
    Fartoux L; Rosmorduc O
    Biol Aujourdhui; 2018; 212(3-4):85-87. PubMed ID: 30973137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.
    Jaeck D; Bronowicki JP; Boudejma K; Bachellier P; Chone L; Nisand G; Bazin C; Pflumio F; Uhl G; Wenger JJ; Boissel P; Bigard MA; Gaucher P; Vetter D; Wolf P; Doffoel M
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():413-5. PubMed ID: 9383352
    [No Abstract]   [Full Text] [Related]  

  • 35. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma.
    Szklaruk J; Silverman PM; Charnsangavej C
    AJR Am J Roentgenol; 2003 Feb; 180(2):441-54. PubMed ID: 12540450
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Stahel RA; Weder W; Lievens Y; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v126-8. PubMed ID: 20555061
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Okines A; Verheij M; Allum W; Cunningham D; Cervantes A;
    Ann Oncol; 2010 May; 21 Suppl 5():v50-4. PubMed ID: 20555102
    [No Abstract]   [Full Text] [Related]  

  • 38. [Palliative therapy of hepatocellular carcinoma. Transarterial chemoembolization (TACE) and thermoablation].
    Steiner P; Brunken C; Begemann P; Bücheler E
    Internist (Berl); 2000 Feb; 41(2 Pt 2):198-204. PubMed ID: 10756435
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current therapeutic strategies for hepatocellular carcinoma].
    Geier A; Schadde E; Müllhaupt B
    MMW Fortschr Med; 2012 Jul; 154(13):63-7; quiz 68-9. PubMed ID: 22957387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.